Barclays PLC boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 6.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 286,475 shares of the company's stock after acquiring an additional 18,458 shares during the quarter. Barclays PLC owned 0.23% of Henry Schein worth $20,882,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Cromwell Holdings LLC increased its holdings in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock worth $26,000 after acquiring an additional 170 shares during the last quarter. Studio Investment Management LLC boosted its position in Henry Schein by 3.8% during the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company's stock worth $341,000 after purchasing an additional 172 shares during the period. Simplify Asset Management Inc. increased its holdings in shares of Henry Schein by 5.0% in the second quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company's stock valued at $237,000 after purchasing an additional 175 shares during the last quarter. Huntington National Bank raised its position in shares of Henry Schein by 16.8% in the third quarter. Huntington National Bank now owns 1,515 shares of the company's stock valued at $110,000 after purchasing an additional 218 shares during the period. Finally, Tempus Wealth Planning LLC lifted its stake in shares of Henry Schein by 6.0% during the 2nd quarter. Tempus Wealth Planning LLC now owns 4,607 shares of the company's stock worth $295,000 after buying an additional 260 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.
In other news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares of the company's stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.14% of the stock is owned by insiders.
A number of brokerages recently commented on HSIC. Evercore ISI upped their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research note on Tuesday, October 8th. StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Barrington Research reiterated an "outperform" rating and set a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Finally, Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price target for the company. Seven analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, Henry Schein currently has an average rating of "Moderate Buy" and a consensus price target of $78.89.
Read Our Latest Analysis on HSIC
HSIC opened at $76.60 on Friday. The firm has a market cap of $9.55 billion, a P/E ratio of 31.52, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87. The business's fifty day moving average is $72.25 and its 200-day moving average is $70.06. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.
Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the prior year, the firm posted $1.32 EPS. The firm's quarterly revenue was up .4% on a year-over-year basis. Sell-side analysts expect that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.